/24-7PressRelease/ - MONROVIA, CA, August 09, 2008 - GTCbio just announced the commencement of its inaugural conference on Global Clinical Trial Operations taking place on September 25-26, 2008 in San Diego, CA.
Outsourcing to CROs has proven to be much more cost effective and less time consuming when conducting clinical trials. The steps to ensuring a successful trial are long and crucial to the approval of a drug. Companies must consider many aspects of a clinical trial design and ask themselves numerous questions such as: how do I identify the right patients, how do I choose a proper site, what are the import and export regulations in other countries? GTCbio's Global Clinical Trial Operations Conference will provide in-depth answers to these questions as well as cover the steps to maximize an outsourcing relationship and identifying the right partner.
The conference brings together top industry leaders including directors, vice presidents, heads, managers, and CROs from all over the world to collaborate and discuss the latest strategies in conducting clinical trials globally. The conference covers the operations and logistics required to conduct early and late stage phases of clinical trials in the U.S., Asia Pacific, Central & South America, and Central & Eastern Europe. Also included are discussions on conducting pediatric clinical trials and the use of technology in clinical trials to improve efficiency.
Keynote presentations will be given by Debasish Roychowdhury, Senior Vice President, Medicines Development, Oncology R&D, at GlaxoSmithKline and Amrit Ray, Vice President, Medical Safety Assessment, GPV&E at Bristol-Myers Squibb.
For more information on attending, presenting a poster, or sponsoring, please visit http://gtcbio.com/conferenceDetails.aspx?id=127.
About GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: Nina Tran, Senior Conference Producer, GTCbio (626) 256-6405, (626) 256-6460 fax, nina.tran@gtcbio.com
# # #
Read more Press Releases from Rania Hafez:- Michael Karin, Professor at UCSD to Give Keynote Speech at 7th Cytokines & Inflammation Conference
- GTCbio Announces its 7th Annual Cytokines & Inflammation Conference
- Samir Hanash, Program Head at the Fred Hutchinson Cancer Research Center to Give Keynote Speech at GTCbio's 2nd Oncology Biomarkers Conference on January 19-20 in Miami, Florida
- GTCbio Announces its 2nd Annual Oncology Biomarkers Conference
- Michael Shih, Director of Business Development at Eisai Inc. and Deepa Talpade, Director of Global Licensing & Strategic Alliances at Schering Plough to Give Joint Featured Presentation at GTCbio's CNS Diseases Partnering & Deal-Making Summit on Dec. 1-2, 2008 in Boston, MA
- GTCBIO ANNOUNCES ITS INAUGURAL CNS DISEASES PARTNERING & DEAL-MAKING SUMMIT
- Johan Luthman, Global Head of Exploratory Medicine Neurology at MerckSerono to Give Plenary Keynote Address at 4th Modern Drug Discovery & Development Summit (Oct. 15-17, 2008 - San Diego, CA)
- Herbert Fritsche, Professor and Chief of Clinical Chemistry at MD Anderson Cancer Center to Give Keynote Presentation at GTCbio's Biomarker Discovery Europe Conference on October 2-3, 2008 in Dublin, Ireland
- Mike Romanos, Vice President of Discovery Technologies at GlaxoSmithKline to Give Keynote Presentation at GTCbio's Biomarker Discovery Europe Conference on October 2-3, 2008 in Dublin, Ireland
- Sharath Hegde, Vice President at Theravance to Give Featured Presentation at GTCbio's Bugs & Drugs Conference on September 22-23, 2008 in San Diego, CA
